Quidel品牌介绍
品牌简介
|
Quidel Corporation（Nasdaq:QDEL）是一家总部位于加利福尼亚州的领先诊断医疗保健制造商，旨在通过开发诊断解决方案来提高全球人民的健康和福祉，从而改善患者的预后，并为医疗保健系统提供经济效益。 Quidel Corporation (Nasdaq: QDEL) is a California-based leading diagnostic healthcare manufacturer serving to enhance the health and well-being of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Quidel commenced operations in 1979 and launched its first products in 1983. Since that time, Quidel has expanded its product base through internal development and acquisition with a focus on increasing its research and development efforts to accelerate the rate of new product introductions. Our core competencies and capabilities include immunoassay development, automated manufacturing, monoclonal antibody characterization and development, and molecular assay development. Our current products fall generally into these categories: (1) lateral flow, where we are market leaders in infectious disease and reproductive health; (2) direct fluorescent antibodies (DFA), with expertise in infectious disease and virology; (3) micro-titer production, with a focus on bone and complement pathway markets; (4) fluorescent immunoassay products (Sofia); and (5) molecular diagnostic products including the world’s first FDA-cleared handheld molecular device, AmpliVue. Additional molecular and Sofia tests are currently in development or in clinical trials as part of a robust product pipeline. |
main products
Molecular Diagnostics
Helicase Dependent Amplification Assays
Real-time RT-PCR Assays
Instrumentation
Controls & Supplies
Immunoassays
Fluorescent Immunoassays
Rapid Test Kits
ELISA Immunoassays
Instrumentation
Controls & Supplies
DHI Cell Culture & Fluorescent Tests
Cell Culture & Cell Lines
Fluorescent Antibody Kits & Reagents
Media & Culture Solutions
Research
Cancer Research Products
Inflammatory & Autoimmune
Metabolic Syndrome
Osteoporosis (Bone Health)
https://www.quidel.com
联系我们
